You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《港股開市》恆指高開289點 科技股造好 中生製藥漲5%
美持續申領失業救濟人數升至2月以來高位,市場憧憬美聯儲放緩加息,道指升345點或1.1%,港股早市高開。恆指高開289點或1.5%,報20,030點;國指高開114點或1.7%,報6,810點;恆生科技指數高開95點或2.3%,報4,203點。 科技股隨外圍高開,騰訊(00700.HK)高開1.1%報339元,阿里巴巴(09988.HK)高開2%報87.3元,美團(03690.HK))、京東(09618.HK)、百度(09888.HK)、網易(09999.HK)及快手(01024.HK)各高開2.5%至3%,嗶哩嗶哩(09626.HK)高開4.2%,小米(01810.HK)高開1.7%報11.04元。 特斯拉(TSLA.US)股價反彈逾8%,電動車股理想(02015.HK)及小鵬(09868.HK)各高開2.1%及3.1%。體育用品股安踏(02020.HK)及李寧(02331.HK)各高開3.2%及2.8%。澳門旅遊局料明年日均旅客量反彈至4萬人,濠賭股銀娛(00027.HK)及金沙中國(01928.HK)各高開1.6%。 其他藍籌方面,匯控(00005.HK)高開0.8%報48.8元,港交所(00388.HK)及友邦(01299.HK)各高開1.5%及1.3%。 中生製藥(01177.HK)獲口服COVID-19治療藥物內地獨家推廣權,股價高開5%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account